BMRN logo

BioMarin Pharmaceutical Inc. (BMRN) Selling, general & administrative expenses

annual SGA:

$0.00-$937.29M(-100.00%)
December 31, 2024

Summary

  • As of today (September 12, 2025), BMRN annual SGA is $0.00, with the most recent change of -$937.29 million (-100.00%) on December 31, 2024.
  • During the last 3 years, BMRN annual SGA has fallen by -$759.38 million (-100.00%).
  • BMRN annual SGA is now -100.00% below its all-time high of $937.29 million, reached on December 31, 2023.

Performance

BMRN SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

quarterly SGA:

$0.00-$206.10M(-100.00%)
June 30, 2025

Summary

  • As of today (September 12, 2025), BMRN quarterly SGA is $0.00, with the most recent change of -$206.10 million (-100.00%) on June 30, 2025.
  • Over the past year, BMRN quarterly SGA has dropped by -$263.00 million (-100.00%).
  • BMRN quarterly SGA is now -100.00% below its all-time high of $275.02 million, reached on December 31, 2023.

Performance

BMRN quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

TTM SGA:

-$291.82M+$657.24M(+69.25%)
June 30, 2025

Summary

  • As of today (September 12, 2025), BMRN TTM SGA is -$291.82 million, with the most recent change of +$657.24 million (+69.25%) on June 30, 2025.
  • Over the past year, BMRN TTM SGA has dropped by -$1.28 billion (-129.54%).
  • BMRN TTM SGA is now -1835.60% below its all-time high of -$15.08 million.

Performance

BMRN TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherBMRNincome statement metrics

Selling, general & administrative expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

BMRN Selling, general & administrative expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-100.0%-100.0%-129.5%
3 y3 years-100.0%-100.0%-136.8%
5 y5 years-100.0%-100.0%-140.5%

BMRN Selling, general & administrative expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.0%at low-100.0%at lowat high+91.4%
5 y5-year-100.0%at low-100.0%at lowat high+95.7%
alltimeall time-100.0%at low-100.0%at low-1835.6%+95.8%

BMRN Selling, general & administrative expenses History

DateAnnualQuarterlyTTM
Jun 2025
-
$0.00(-100.0%)
$459.60M(-36.4%)
Mar 2025
-
$206.10M(>+9900.0%)
$722.60M(-2.7%)
Dec 2024
$0.00(-100.0%)
$0.00(-100.0%)
$742.40M(-27.0%)
Sep 2024
-
$253.50M(-3.6%)
$1.02B(+3.0%)
Jun 2024
-
$263.00M(+16.4%)
$987.85M(+5.1%)
Mar 2024
-
$225.90M(-17.9%)
$940.19M(+0.3%)
Dec 2023
$937.29M(+9.8%)
$275.02M(+22.8%)
$937.29M(+3.2%)
Sep 2023
-
$223.93M(+4.0%)
$908.01M(+0.8%)
Jun 2023
-
$215.34M(-3.4%)
$900.89M(+2.1%)
Mar 2023
-
$223.00M(-9.3%)
$882.39M(+3.3%)
Dec 2022
$854.01M(+12.5%)
$245.74M(+13.3%)
$854.01M(+3.4%)
Sep 2022
-
$216.82M(+10.2%)
$825.83M(+4.2%)
Jun 2022
-
$196.84M(+1.1%)
$792.35M(+1.6%)
Mar 2022
-
$194.62M(-10.5%)
$779.68M(+2.7%)
Dec 2021
$759.38M(+2.9%)
$217.56M(+18.7%)
$759.38M(+3.0%)
Sep 2021
-
$183.33M(-0.4%)
$737.32M(+0.5%)
Jun 2021
-
$184.16M(+5.6%)
$733.44M(+1.2%)
Mar 2021
-
$174.32M(-10.8%)
$724.69M(-1.8%)
Dec 2020
$737.67M(+8.3%)
$195.51M(+9.0%)
$737.67M(+1.0%)
Sep 2020
-
$179.45M(+2.3%)
$730.06M(+1.3%)
Jun 2020
-
$175.41M(-6.3%)
$720.72M(+2.1%)
Mar 2020
-
$187.29M(-0.3%)
$706.06M(+3.7%)
Dec 2019
$680.92M(+12.7%)
$187.90M(+10.5%)
$680.92M(+3.6%)
Sep 2019
-
$170.11M(+5.8%)
$657.20M(+3.4%)
Jun 2019
-
$160.75M(-0.9%)
$635.65M(+1.2%)
Mar 2019
-
$162.16M(-1.2%)
$628.17M(+3.9%)
Dec 2018
$604.35M(+9.0%)
$164.17M(+10.5%)
$604.35M(+0.6%)
Sep 2018
-
$148.57M(-3.1%)
$600.46M(+3.1%)
Jun 2018
-
$153.28M(+10.8%)
$582.43M(+1.7%)
Mar 2018
-
$138.34M(-13.7%)
$572.65M(+3.3%)
Dec 2017
$554.34M(+16.3%)
$160.28M(+22.8%)
$554.34M(+3.2%)
Sep 2017
-
$130.53M(-9.0%)
$537.01M(-7.8%)
Jun 2017
-
$143.50M(+19.6%)
$582.74M(-2.6%)
Mar 2017
-
$120.02M(-16.0%)
$598.51M(-5.8%)
Dec 2016
$476.59M(+18.5%)
$142.96M(-18.9%)
$635.39M(+4.8%)
Sep 2016
-
$176.26M(+10.7%)
$606.34M(+15.7%)
Jun 2016
-
$159.28M(+1.5%)
$524.13M(+12.4%)
Mar 2016
-
$156.90M(+37.7%)
$466.37M(+15.9%)
Dec 2015
$402.27M(+33.1%)
$113.91M(+21.1%)
$402.27M(+3.6%)
Sep 2015
-
$94.04M(-7.4%)
$388.13M(+5.3%)
Jun 2015
-
$101.51M(+9.4%)
$368.69M(+10.0%)
Mar 2015
-
$92.81M(-7.0%)
$335.27M(+10.8%)
Dec 2014
$302.16M(+28.4%)
$99.77M(+33.7%)
$302.53M(+10.2%)
Sep 2014
-
$74.60M(+9.6%)
$274.57M(+4.9%)
Jun 2014
-
$68.09M(+13.4%)
$261.81M(+7.1%)
Mar 2014
-
$60.07M(-16.3%)
$244.38M(+3.8%)
Dec 2013
$235.36M(+18.8%)
$71.81M(+16.1%)
$235.36M(+7.7%)
Sep 2013
-
$61.84M(+22.1%)
$218.60M(+7.6%)
Jun 2013
-
$50.66M(-0.8%)
$203.09M(-0.4%)
Mar 2013
-
$51.05M(-7.3%)
$203.97M(+2.9%)
Dec 2012
$198.17M(+12.5%)
$55.05M(+18.8%)
$198.17M(+2.6%)
Sep 2012
-
$46.34M(-10.1%)
$193.21M(-0.2%)
Jun 2012
-
$51.54M(+13.9%)
$193.53M(+5.1%)
Mar 2012
-
$45.25M(-9.7%)
$184.10M(+1.3%)
DateAnnualQuarterlyTTM
Dec 2011
$176.10M(+16.1%)
$50.09M(+7.4%)
$181.70M(+4.6%)
Sep 2011
-
$46.65M(+10.8%)
$173.71M(+5.3%)
Jun 2011
-
$42.12M(-1.7%)
$164.96M(+3.0%)
Mar 2011
-
$42.84M(+1.8%)
$160.12M(+5.8%)
Dec 2010
$151.72M(+22.1%)
$42.10M(+11.1%)
$151.28M(+2.6%)
Sep 2010
-
$37.90M(+1.7%)
$147.49M(+7.0%)
Jun 2010
-
$37.28M(+9.6%)
$137.81M(+5.2%)
Mar 2010
-
$34.00M(-11.2%)
$131.06M(+4.2%)
Dec 2009
$124.29M(+16.6%)
$38.31M(+35.7%)
$125.83M(+8.2%)
Sep 2009
-
$28.22M(-7.6%)
$116.25M(-0.6%)
Jun 2009
-
$30.53M(+6.1%)
$116.99M(+4.8%)
Mar 2009
-
$28.77M(+0.1%)
$111.67M(+4.8%)
Dec 2008
$106.57M(+37.4%)
$28.73M(-0.8%)
$106.57M(+4.8%)
Sep 2008
-
$28.96M(+14.9%)
$101.73M(+10.0%)
Jun 2008
-
$25.20M(+6.5%)
$92.48M(+8.9%)
Mar 2008
-
$23.67M(-0.9%)
$84.92M(+9.5%)
Dec 2007
$77.54M(+58.1%)
$23.89M(+21.2%)
$77.54M(+14.7%)
Sep 2007
-
$19.71M(+11.7%)
$67.62M(+12.3%)
Jun 2007
-
$17.65M(+8.4%)
$60.20M(+10.6%)
Mar 2007
-
$16.28M(+16.6%)
$54.42M(+11.0%)
Dec 2006
$49.03M(+18.0%)
$13.97M(+13.7%)
$49.03M(+6.3%)
Sep 2006
-
$12.29M(+3.5%)
$46.13M(+5.7%)
Jun 2006
-
$11.87M(+8.9%)
$43.64M(+4.2%)
Mar 2006
-
$10.90M(-1.6%)
$41.89M(+0.8%)
Dec 2005
$41.56M(+10.5%)
$11.08M(+13.1%)
$41.56M(-5.1%)
Sep 2005
-
$9.80M(-3.2%)
$43.78M(-0.1%)
Jun 2005
-
$10.12M(-4.3%)
$43.85M(+6.2%)
Mar 2005
-
$10.57M(-20.6%)
$41.27M(+20.0%)
Dec 2004
$37.61M(+161.2%)
$13.30M(+34.9%)
$34.39M(+29.5%)
Sep 2004
-
$9.86M(+30.8%)
$26.56M(+44.6%)
Jun 2004
-
$7.54M(+104.4%)
$18.36M(+20.1%)
Mar 2004
-
$3.69M(-32.6%)
$15.29M(+4.5%)
Dec 2003
$14.40M(+1.8%)
$5.47M(+229.4%)
$14.62M(+59.9%)
Sep 2003
-
$1.66M(-62.7%)
$9.15M(-19.9%)
Jun 2003
-
$4.46M(+47.5%)
$11.42M(+13.9%)
Mar 2003
-
$3.02M(>+9900.0%)
$10.03M(-8.3%)
Dec 2002
$14.14M(+110.5%)
$0.00(-100.0%)
$10.93M(0.0%)
Sep 2002
-
$3.94M(+28.7%)
$10.93M(+9.5%)
Jun 2002
-
$3.06M(-22.0%)
$9.98M(+8.2%)
Mar 2002
-
$3.93M(>+9900.0%)
$9.23M(+23.0%)
Dec 2001
$6.72M(-23.8%)
$0.00(-100.0%)
$7.50M(0.0%)
Sep 2001
-
$2.99M(+29.6%)
$7.50M(+66.3%)
Jun 2001
-
$2.31M(+4.8%)
$4.51M(+104.8%)
Mar 2001
-
$2.20M(>+9900.0%)
$2.20M(>+9900.0%)
Dec 2000
$8.81M(+29.5%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2000
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2000
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2000
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1999
$6.80M(+92.7%)
$0.00(0.0%)
$0.00(0.0%)
Sep 1999
-
$0.00(0.0%)
$0.00(0.0%)
Jun 1999
-
$0.00(0.0%)
$0.00(0.0%)
Mar 1999
-
$0.00(0.0%)
$0.00(0.0%)
Dec 1998
$3.53M(>+9900.0%)
-
-
Dec 1998
-
$0.00
$0.00
Dec 1997
$0.00
-
-

FAQ

  • What is BioMarin Pharmaceutical Inc. annual SGA?
  • What is the all time high annual SGA for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. annual SGA year-on-year change?
  • What is BioMarin Pharmaceutical Inc. quarterly SGA?
  • What is the all time high quarterly SGA for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. quarterly SGA year-on-year change?
  • What is BioMarin Pharmaceutical Inc. TTM SGA?
  • What is the all time high TTM SGA for BioMarin Pharmaceutical Inc.?
  • What is BioMarin Pharmaceutical Inc. TTM SGA year-on-year change?

What is BioMarin Pharmaceutical Inc. annual SGA?

The current annual SGA of BMRN is $0.00

What is the all time high annual SGA for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high annual SGA is $937.29M

What is BioMarin Pharmaceutical Inc. annual SGA year-on-year change?

Over the past year, BMRN annual SGA has changed by -$937.29M (-100.00%)

What is BioMarin Pharmaceutical Inc. quarterly SGA?

The current quarterly SGA of BMRN is $0.00

What is the all time high quarterly SGA for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high quarterly SGA is $275.02M

What is BioMarin Pharmaceutical Inc. quarterly SGA year-on-year change?

Over the past year, BMRN quarterly SGA has changed by -$263.00M (-100.00%)

What is BioMarin Pharmaceutical Inc. TTM SGA?

The current TTM SGA of BMRN is -$291.82M

What is the all time high TTM SGA for BioMarin Pharmaceutical Inc.?

BioMarin Pharmaceutical Inc. all-time high TTM SGA is -$15.08M

What is BioMarin Pharmaceutical Inc. TTM SGA year-on-year change?

Over the past year, BMRN TTM SGA has changed by -$1.28B (-129.54%)
On this page